Search - tctmd.com

Displaying 221 - 240 of 386

Sort: Relevancy | Date

News Daily News

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Yael L. Maxwell

March 30, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Todd Neale

February 07, 2016

News Daily News

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

Yael L. Maxwell

January 05, 2016

News Daily News

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Yael L. Maxwell

January 05, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

Presentation TCT 2015

Identifying and Studying Data Gaps: DAPT Duration What's Settled, and What's Not?

Presenter: Deepak L. Bhatt, Martin Rose, John A. Bittl

October 14, 2015

Presentation TCT 2015

Optimal DAPT Duration After DES

Presenter: George D. Dangas, Paul A. Gurbel, Somjot S. Brar

October 13, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Presentation TCT 2015

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Presentation TCT 2015

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Presenter: John A. Bittl, Gary L. Schaer, Gennaro Giustino

October 12, 2015

Presentation TCT 2015

Is Dropping Aspirin the Magic Solution?

Presenter: John A. Bittl, Gary L. Schaer, Pascal Vranckx

October 12, 2015

Presentation TCT 2015

Risk vs Benefit: Can We Determine Which Patients Should Be Treated With Long-term DAPT?

Presenter: John A. Bittl, Gary L. Schaer, Matthew T. Roe

October 12, 2015

Advertisement

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Complex Lesions, Thrombus During PCI May Spell Trouble After DES Implantation

Symptom Duration May Be More Important Than D2B for STEMI, HORIZONS-AMI Substudy Suggests

HORIZONS-AMI 亚组研究表明，STEMI 患者的症状持续时间可能比 D2B 更重要

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Identifying and Studying Data Gaps: DAPT Duration What's Settled, and What's Not?

Optimal DAPT Duration After DES

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

DAPT Duration Case 2: An Elderly Patient With CKD and Left Main Bifurcation Stenting Postdischarge Course

DAPT Duration Case 1: An Elderly Patient With CKD and Left Main Bifurcation Stenting In-Hospital Course

Is Dropping Aspirin the Magic Solution?

Risk vs Benefit: Can We Determine Which Patients Should Be Treated With Long-term DAPT?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content